Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells.

Titanium (Ti) surface roughness affects proliferation, differentiation, and matrix production of MG-63 osteoblast-like cells. Cytokines and growth factors produced in the milieu surrounding an implant may also be influenced by its surface, thereby modulating the healing process. This study examined the effect of surface roughness on the production of two factors known to have potent effects on bone, prostaglandin E2 (PGE2) and transforming growth factor beta 1 (TGF-beta 1). MG-63 cells were cultured on Ti disks of varying roughness. The surfaces were ranked from smoothest to roughest: electropolished (EP), pretreated with hydrofluoric acid-nitric acid (PT), fine sand-blasted, etched with HCl and H2SO4, and washed (EA), coarse sand-blasted, etched with HCl and H2SO4, and washed (CA), and Ti plasma-sprayed (TPS). Cells were cultured in 24-well polystyrene (plastic) dishes as controls and to determine when confluence was achieved. Media were collected and cell number determined 24 h postconfluence. PGE2 and TGF-beta 1 levels in the conditioned media were determined using commercial radioimmunoassay and enzyme-linked immunosorbent assay kits, respectively. There was an inverse relationship between cell number and Ti surface roughness. Total PGE2 content in the media of cultures grown on the three roughest surfaces (FA, CA, and TPS) was significantly increased 1.5-4.0 times over that found in media of cultures grown on plastic or smooth surfaces. When PGE2 production was expressed per cell number, CA and TPS cultures exhibited six- to eightfold increases compared to cultures on plastic and smooth surfaces. There was a direct relationship between TGF-beta 1 production and surface roughness, both in terms of total TGF-beta 1 per culture and when normalized for cell number. TGF-beta 1 production on rough surfaces (CA and TPS) was three to five times higher than on plastic. These studies indicate that substrate surface roughness affects cytokine and growth factor production by MG-63 cells, suggesting that surface roughness may modulate the activity of cells interacting with an implant, and thereby affect tissue healing and implant success.

[1]  L. Bonewald,et al.  Role of transforming growth factor-beta in bone remodeling. , 1990, Clinical orthopaedics and related research.

[2]  E. Canalis,et al.  Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. , 1991, Endocrinology.

[3]  L. Raisz,et al.  Inhibition of bone collagen synthesis by prostaglandin E2 in organ culture. , 1974, Prostaglandins.

[4]  B. Boyan,et al.  Culture surfaces coated with various implant materials affect chondrocyte growth and metabolism , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  G. Stein,et al.  Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[6]  L. Raisz,et al.  Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. , 1990, Endocrinology.

[7]  R. Dziak,et al.  Effects of prostaglandins on rat calvarial bone-cell calcium. , 1984, Archives of oral biology.

[8]  B D Boyan,et al.  Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). , 1995, Journal of biomedical materials research.

[9]  L. Bonewald,et al.  Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term cultures of fetal rat calvarial osteoblasts , 1994 .

[10]  B D Boyan,et al.  Role of material surfaces in regulating bone and cartilage cell response. , 1996, Biomaterials.

[11]  B. Riggs,et al.  Effects of transforming growth factor beta (TGFβ) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells , 1994 .

[12]  R. Dziak.  Prostaglandins as Mediators of Bone Cell Metabolism , 1985 .

[13]  L. Bonewald,et al.  Localization of 1,25-(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. , 1989, The Journal of biological chemistry.

[14]  D Buser,et al.  Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. , 1991, Journal of biomedical materials research.

[15]  D. Rosen,et al.  Transforming Growth Factor-β2 Enhances the Osteoinductive Activity of a Bovine Bone-Derived Fraction Containing Bone Morphogenetic Protein-2 and 3 , 1991 .

[16]  L. Raisz,et al.  Stimulation of bone formation by prostaglandin E2. , 1984, Prostaglandins.

[17]  S D Cook,et al.  An evaluation of variables influencing implant fixation by direct bone apposition. , 1985, Journal of biomedical materials research.

[18]  G. Stein,et al.  Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  G. Stein,et al.  The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids). , 1993, The Journal of oral implantology.

[20]  M. Sporn,et al.  Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.

[21]  L. Bonewald,et al.  Stimulation of matrix vesicle enzyme activity in osteoblast-like cells by 1,25(OH)2D3 and transforming growth factor β (TGFβ) , 1992 .

[22]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[23]  B. Boyan,et al.  Regulation of prostaglandin E2 production by vitamin D metabolites in growth zone and resting zone chondrocyte cultures is dependent on cell maturation. , 1992, Bone.

[24]  L. Bonewald,et al.  Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. , 1993, Endocrinology.

[25]  S. Bruder,et al.  In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. , 1991, Experimental cell research.

[26]  J. Aubin,et al.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone , 1988, The Journal of cell biology.

[27]  L. Bonewald,et al.  Differential regulation of prostaglandin E2 synthesis and phospholipase A2 activity by 1,25-(OH)2D3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63). , 1992, Bone.

[28]  J. Aubin,et al.  Effects of dexamethasone and vitamin D3 on cartilage differentiation in a clonal chondrogenic cell population. , 1989, Endocrinology.

[29]  G. Stein,et al.  Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Franceschi,et al.  1α, 25‐Dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line , 1985 .

[31]  L. Bonewald,et al.  Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). , 1992, The Journal of biological chemistry.

[32]  B. Boyan,et al.  Underlying mechanisms at the bone–biomaterial interface. , 1994, Journal of cellular biochemistry.